Pulike Biological Engineering, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000025N0
CNY
11.69
0.02 (0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,085.04
1,038.13
1,246.69
1,225.22
1,093.65
923.97
659.53
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,085.04
1,038.13
1,246.69
1,225.22
1,093.65
923.97
659.53
Raw Material Cost
496.07
467.80
528.30
496.71
410.49
357.62
280.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.23
0.26
1.12
1.08
0.23
0.08
0.62
Selling and Distribution Expenses
318.60
368.04
447.57
469.16
382.33
287.32
215.44
Other Expenses
7.67
8.56
8.64
7.91
7.26
10.30
8.08
Total Expenditure (Excl Depreciation)
891.60
921.66
1,063.38
1,046.06
865.64
747.98
577.72
Operating Profit (PBDIT) excl Other Income
193.4
116.5
183.29999999999998
179.20000000000002
228
176
81.8
Other Income
46.61
14.48
46.54
53.27
50.73
67.09
51.34
Operating Profit (PBDIT)
347.50
240.10
313.55
299.83
331.83
288.49
172.06
Interest
0.23
0.26
1.12
1.08
0.23
0.08
0.62
Exceptional Items
9.60
-8.97
-17.72
-25.57
20.41
24.32
7.93
Gross Profit (PBDT)
588.97
570.33
718.39
728.51
683.16
566.36
378.64
Depreciation
123.05
120.31
91.23
75.33
59.46
51.21
50.38
Profit Before Tax
233.82
110.56
203.48
197.85
292.55
261.53
128.99
Tax
22.34
5.96
20.10
9.90
40.04
32.26
7.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
184.99
92.81
174.52
167.82
244.14
227.74
109.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
184.99
92.81
174.52
167.82
244.14
227.74
109.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
184.99
92.81
174.52
167.82
244.14
227.74
109.25
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,605.93
2,626.09
2,723.87
2,803.97
1,800.45
1,709.65
1,658.04
Earnings per share (EPS)
0.54
0.27
0.5
0.52
0.78
0.72
0.34
Diluted Earnings per share
0.54
0.27
0.5
0.52
0.78
0.72
0.34
Operating Profit Margin (Excl OI)
16.39%
10.14%
14.1%
13.98%
20.27%
18.42%
10.67%
Gross Profit Margin
32.89%
22.24%
23.64%
22.3%
32.19%
33.85%
27.2%
PAT Margin
17.05%
8.94%
14.0%
13.7%
22.32%
24.65%
16.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 4.52% vs -16.73% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 99.35% vs -46.82% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 33.38% vs -15.51% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -33.33% vs -72.73% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Pulike Biological Engineering, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,085.04
0
1,085.04
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,085.04
0
1,085.04
Raw Material Cost
496.07
0
496.07
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.23
0
0.23
Selling and Distribution Expenses
318.60
0
318.60
Other Expenses
7.67
0.00
7.67
Total Expenditure (Excl Depreciation)
891.60
0
891.60
Operating Profit (PBDIT) excl Other Income
193.44
0.00
193.44
Other Income
46.61
0
46.61
Operating Profit (PBDIT)
347.50
0
347.50
Interest
0.23
0
0.23
Exceptional Items
9.60
0
9.60
Gross Profit (PBDT)
588.97
0
588.97
Depreciation
123.05
0
123.05
Profit Before Tax
233.82
0
233.82
Tax
22.34
0
22.34
Provisions and contingencies
0
0
0.00
Profit After Tax
184.99
0
184.99
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
184.99
0
184.99
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
184.99
0
184.99
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,605.93
0
2,605.93
Earnings per share (EPS)
0.54
0
0.54
Diluted Earnings per share
0.54
0
0.54
Operating Profit Margin (Excl OI)
16.39%
0%
0.00
16.39%
Gross Profit Margin
32.89%
0%
0.00
32.89%
PAT Margin
17.05%
0%
0.00
17.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 108.50 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 4.52% vs -16.73% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 18.50 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 99.35% vs -46.82% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.09 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 33.38% vs -15.51% in Dec 2024

Annual - Interest
Interest 0.02 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -33.33% vs -72.73% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.39%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024